Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
LUC1601
Lung cancer tissue array (adenocarcinoma), 160 cores from normal (3 cases) and various types of adenocarcinoma (77 cases with TNM staging data) tissues in duplicates.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$319
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
I | |
J | |
TNM Classification: Lung carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed or tumor proven by the presence of malignant cell in sputum or bronchial washing but not visualized by imaging of bronchoscopy;
TO - No evidence of primary tumor;
Tis- Carcinoma in situ;
T1 - Tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than lobular bronchus;
T2 - Tumor with any of the following features of size or extent; more than 3 cm in greatest dimension; involves main bronchus, 2 cm more proximal to carina; invades visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but not involve the entire lung;
T3 - Tumor of any size that directly invades any of the followings: chest wall (including superior sulcus tumor), diaphragm, mediastinal pleura, parietal pericardium; tumors in the main bronchus less than 3 cm distal to the carina; associated with atelectasis or obstructive pneumonitis of entire lung;
T4 - Tumor of any size that invades any of the following: mediastinum, heart, great vessel, trachea, esophagus, vertebral body, carina, separate tumor nodule(s) in the same,lobe; tumor with malignant pleural effusion.
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed;
NO - No regional lymph node metastasis;
N1 - Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension;
N2 - Metastasis in ipsilateral mediastinal and/or subcarinal lymph nodes;
N3 - Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral, scalene, or supraclavicular lymph nodes.
M - Distant metastasis
MX - Distant metastasis cannot be assessed MO - No distant metastasis;
M1 - Distant metastasis, including separate tumor nodule(s) in a different lobe (ipsilateral or contralateral).
Human
80
160
1.1 mm
4um
10
16
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in lung adenocarcinomas.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | F | 52 | Lung | Normal | |||
A02 | M | 66 | Lung | Normal | |||
A03 | M | 54 | Lung | Adenocarcinoma | III | T2N1M0 | |
A04 | M | 68 | Lung | Adenocarcinoma | III | T2N0M0 | |
A05 | M | 66 | Lung | Adenosquamous carcinoma | T3N0M0 | ||
A06 | F | 77 | Lung | Adenocarcinoma | I~II | T2N0M0 | |
A07 | M | 51 | Lung | Adenocarcinoma | III | T2N0M0 | |
A08 | M | 77 | Lung | Normal | |||
A09 | F | 45 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
A10 | M | 55 | Lung | Adenocarcinoma | II | T2N0M0 | |
A11 | F | 57 | Lung | Adenocarcinoma | III | T2N0M0 | |
A12 | M | 79 | Lung | Adenocarcinoma | II | T2N1M0 | |
A13 | F | 61 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
A14 | M | 34 | Lung | Adenocarcinoma | II | T2N1M0 | |
A15 | F | 56 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
A16 | F | 59 | Lung | Adenocarcinoma | II | T2N0M0 | |
B01 | F | 52 | Lung | Normal | |||
B02 | M | 66 | Lung | Normal | |||
B03 | M | 54 | Lung | Adenocarcinoma | III | T2N1M0 | |
B04 | M | 68 | Lung | Adenocarcinoma | III | T2N0M0 | |
B05 | M | 66 | Lung | Adenosquamous carcinoma | T3N0M0 | ||
B06 | F | 77 | Lung | Adenocarcinoma | I~II | T2N0M0 | |
B07 | M | 51 | Lung | Adenocarcinoma | III | T2N0M0 | |
B08 | M | 77 | Lung | Normal | |||
B09 | F | 45 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
B10 | M | 55 | Lung | Adenocarcinoma | II | T2N0M0 | |
B11 | F | 57 | Lung | Adenocarcinoma | III | T2N0M0 | |
B12 | M | 79 | Lung | Adenocarcinoma | II | T2N1M0 | |
B13 | F | 61 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
B14 | M | 34 | Lung | Adenocarcinoma | II | T2N1M0 | |
B15 | F | 56 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
B16 | F | 59 | Lung | Adenocarcinoma | II | T2N0M0 | |
C01 | M | 56 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
C02 | M | 57 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
C03 | F | 46 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
C04 | F | 70 | Lung | Adenocarcinoma | II | T1N0M0 | |
C05 | F | 50 | Lung | Papillary carcinoma | T2N0M0 | ||
C06 | F | 66 | Lung | Adenocarcinoma | II | T2N1M0 | |
C07 | F | 54 | Lung | Adenocarcinoma | III | T2N0M0 | |
C08 | M | 62 | Lung | Bronchioloalveolar carcinoma | T1N0M0 | ||
C09 | F | 60 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
C10 | M | 73 | Lung | Adenocarcinoma | II | T2N1M0 | |
C11 | M | 53 | Lung | Adenocarcinoma | III | T2N0M0 | |
C12 | M | 52 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
C13 | M | 79 | Lung | Adenocarcinoma | II | T2N0M0 | |
C14 | F | 55 | Lung | Adenocarcinoma | II | T2N0M0 | |
C15 | M | 57 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
C16 | F | 57 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
D01 | M | 56 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
D02 | M | 57 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
D03 | F | 46 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
D04 | F | 70 | Lung | Adenocarcinoma | II | T1N0M0 | |
D05 | F | 50 | Lung | Papillary carcinoma | T2N0M0 | ||
D06 | F | 66 | Lung | Adenocarcinoma | II | T2N1M0 | |
D07 | F | 54 | Lung | Adenocarcinoma | III | T2N0M0 | |
D08 | M | 62 | Lung | Bronchioloalveolar carcinoma | T1N0M0 | ||
D09 | F | 60 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
D10 | M | 73 | Lung | Adenocarcinoma | II | T2N1M0 | |
D11 | M | 53 | Lung | Adenocarcinoma | III | T2N0M0 | |
D12 | M | 52 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
D13 | M | 79 | Lung | Adenocarcinoma | II | T2N0M0 | |
D14 | F | 55 | Lung | Adenocarcinoma | II | T2N0M0 | |
D15 | M | 57 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
D16 | F | 57 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
E01 | M | 59 | Lung | Mucinous adenocarcinoma | T2N1M0 | ||
E02 | F | 37 | Lung | Papillary carcinoma | T2N1M0 | ||
E03 | F | 68 | Lung | Mucinous adenocarcinoma | T2N0M0 | ||
E04 | F | 68 | Lung | Adenocarcinoma | II | T2N0M0 | |
E05 | F | 55 | Lung | Adenocarcinoma | II | T2N0M0 | |
E06 | M | 58 | Lung | Adenocarcinoma | I~II | T2N0M0 | |
E07 | M | 48 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
E08 | F | 51 | Lung | Adenocarcinoma | II | T2N1M0 | |
E09 | F | 51 | Lung | Adenocarcinoma | II | T2N0M0 | |
E10 | M | 74 | Lung | Adenocarcinoma | III | T2N0M0 | |
E11 | M | 75 | Lung | Adenocarcinoma | I | T2N0M0 | |
E12 | M | 65 | Lung | Adenocarcinoma | II | T2N0M0 | |
E13 | M | 44 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
E14 | M | 70 | Lung | Adenocarcinoma | III | T2N0M0 | |
E15 | M | 54 | Lung | Adenocarcinoma | I~II | T2N0M0 | |
E16 | F | 64 | Lung | Adenocarcinoma | II | T2N0M0 | |
F01 | M | 59 | Lung | Mucinous adenocarcinoma | T2N1M0 | ||
F02 | F | 37 | Lung | Papillary carcinoma | T2N1M0 | ||
F03 | F | 68 | Lung | Mucinous adenocarcinoma | T2N0M0 | ||
F04 | F | 68 | Lung | Adenocarcinoma | II | T2N0M0 | |
F05 | F | 55 | Lung | Adenocarcinoma | II | T2N0M0 | |
F06 | M | 58 | Lung | Adenocarcinoma | I~II | T2N0M0 | |
F07 | M | 48 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
F08 | F | 51 | Lung | Adenocarcinoma | II | T2N1M0 | |
F09 | F | 51 | Lung | Adenocarcinoma | II | T2N0M0 | |
F10 | M | 74 | Lung | Adenocarcinoma | III | T2N0M0 | |
F11 | M | 75 | Lung | Adenocarcinoma | I | T2N0M0 | |
F12 | M | 65 | Lung | Adenocarcinoma | II | T2N0M0 | |
F13 | M | 44 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
F14 | M | 70 | Lung | Adenocarcinoma | III | T2N0M0 | |
F15 | M | 54 | Lung | Adenocarcinoma | I~II | T2N0M0 | |
F16 | F | 64 | Lung | Adenocarcinoma | II | T2N0M0 | |
G01 | M | 59 | Lung | Adenocarcinoma | II | T2N0M0 | |
G02 | M | 42 | Lung | Adenocarcinoma | II~III | T2N0M0 | |
G03 | M | 48 | Lung | Adenocarcinoma | I~II | T2N1M0 | |
G04 | M | 66 | Lung | Adenocarcinoma | II | T2N1M0 | |
G05 | F | 72 | Lung | Bronchioloalveolar carcinoma | T2N1M0 | ||
G06 | F | 58 | Lung | Adenocarcinoma | II | T2N0M0 | |
G07 | M | 55 | Lung | Adenocarcinoma | II | T2N1M0 | |
G08 | M | 60 | Lung | Adenocarcinoma | II~III | T2N0M0 | |
G09 | M | 54 | Lung | Adenocarcinoma | III | T2N1M0 | |
G10 | M | 58 | Lung | Adenocarcinoma | II | T1N0M0 | |
G11 | F | 66 | Lung | Adenocarcinoma | III | T2N1M0 | |
G12 | M | 55 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
G13 | F | 64 | Lung | Adenocarcinoma | II | T2N0M0 | |
G14 | M | 44 | Lung | Adenocarcinoma | II | T3N1M0 | |
G15 | F | 62 | Lung | Adenocarcinoma | I~II | T2N1M0 | |
G16 | F | 62 | Lung | Adenocarcinoma | II | T2N0M0 | |
H01 | M | 59 | Lung | Adenocarcinoma | II | T2N0M0 | |
H02 | M | 42 | Lung | Adenocarcinoma | II~III | T2N0M0 | |
H03 | M | 48 | Lung | Adenocarcinoma | I~II | T2N1M0 | |
H04 | M | 66 | Lung | Adenocarcinoma | II | T2N1M0 | |
H05 | F | 72 | Lung | Bronchioloalveolar carcinoma | T2N1M0 | ||
H06 | F | 58 | Lung | Adenocarcinoma | II | T2N0M0 | |
H07 | M | 55 | Lung | Adenocarcinoma | II | T2N1M0 | |
H08 | M | 60 | Lung | Adenocarcinoma | II~III | T2N0M0 | |
H09 | M | 54 | Lung | Adenocarcinoma | III | T2N1M0 | |
H10 | M | 58 | Lung | Adenocarcinoma | II | T1N0M0 | |
H11 | F | 66 | Lung | Adenocarcinoma | III | T2N1M0 | |
H12 | M | 55 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
H13 | F | 64 | Lung | Adenocarcinoma | II | T2N0M0 | |
H14 | M | 44 | Lung | Adenocarcinoma | II | T3N1M0 | |
H15 | F | 62 | Lung | Adenocarcinoma | I~II | T2N1M0 | |
H16 | F | 62 | Lung | Adenocarcinoma | II | T2N0M0 | |
I01 | M | 70 | Lung | Adenocarcinoma | II | T2N1M0 | |
I02 | M | 68 | Lung | Papillary carcinoma | T2N1M0 | ||
I03 | F | 61 | Lung | Adenocarcinoma | III | T3N0M0 | |
I04 | F | 55 | Lung | Mucinous adenocarcinoma | T2N0M0 | ||
I05 | F | 55 | Lung | Adenocarcinoma | II | T2N1M0 | |
I06 | F | 41 | Lung | Mucinous adenocarcinoma | T2N0M0 | ||
I07 | F | 75 | Lung | Adenocarcinoma | II | T2N1M0 | |
I08 | F | 47 | Lung | Adenocarcinoma | I | T2N0M0 | |
I09 | F | 43 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
I10 | F | 53 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
I11 | F | 55 | Lung | Adenocarcinoma | I~II | T2N1M0 | |
I12 | M | 62 | Lung | Adenocarcinoma | II | T1N0M0 | |
I13 | M | 54 | Lung | Adenocarcinoma | III | T2N0M0 | |
I14 | M | 62 | Lung | Adenocarcinoma | III | T1N0M0 | |
I15 | M | 51 | Lung | Adenocarcinoma | II~III | T1N0M0 | |
I16 | M | 63 | Lung | Adenocarcinoma | II | T2N0M0 | |
J01 | M | 70 | Lung | Adenocarcinoma | II | T2N1M0 | |
J02 | M | 68 | Lung | Papillary carcinoma | T2N1M0 | ||
J03 | F | 61 | Lung | Adenocarcinoma | III | T3N0M0 | |
J04 | F | 55 | Lung | Mucinous adenocarcinoma | T2N0M0 | ||
J05 | F | 55 | Lung | Adenocarcinoma | II | T2N1M0 | |
J06 | F | 41 | Lung | Mucinous adenocarcinoma | T2N0M0 | ||
J07 | F | 75 | Lung | Adenocarcinoma | II | T2N1M0 | |
J08 | F | 47 | Lung | Adenocarcinoma | I | T2N0M0 | |
J09 | F | 43 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
J10 | F | 53 | Lung | Adenocarcinoma | II~III | T2N1M0 | |
J11 | F | 55 | Lung | Adenocarcinoma | I~II | T2N1M0 | |
J12 | M | 62 | Lung | Adenocarcinoma | II | T1N0M0 | |
J13 | M | 54 | Lung | Adenocarcinoma | III | T2N0M0 | |
J14 | M | 62 | Lung | Adenocarcinoma | III | T1N0M0 | |
J15 | M | 51 | Lung | Adenocarcinoma | II~III | T1N0M0 | |
J16 | M | 63 | Lung | Adenocarcinoma | II | T2N0M0 | |
null |
